BioCentury
ARTICLE | Company News

Certara, Arsenal Capital deal

January 6, 2014 8:00 AM UTC

Private equity firm Arsenal Capital acquired drug discovery and development software company Certara on Dec. 19, 2013. James Rothman, who is an operating partner at Arsenal Capital, joined Certara's board. William Blair & Co. was financial advisor, and Davis Polk was legal advisor to Certara. DLA Piper was legal advisor to Arsenal. Arsenal said financial terms are not disclosed, and Certara declined to disclose its revenues. ...